These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 16157424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK, Alex M, Czerny CP, Böhm R, Beyer W.
    Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
    [Abstract] [Full Text] [Related]

  • 3. BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge.
    Köhler SM, Baillie LW, Beyer W.
    Vaccine; 2015 Jun 04; 33(24):2771-7. PubMed ID: 25917676
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK, Rossi CA, Kang AS, Morrow PR, Lee JS, Welkos SL.
    Microb Pathog; 2005 Jun 04; 38(5-6):209-25. PubMed ID: 15925272
    [Abstract] [Full Text] [Related]

  • 7. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y, Qiu J, Zhou Y, Farhangfar F, Hester J, Lin AY, Decker WK.
    Vaccine; 2008 Jan 30; 26(5):614-22. PubMed ID: 18166249
    [Abstract] [Full Text] [Related]

  • 8. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
    Price BM, Liner AL, Park S, Leppla SH, Mateczun A, Galloway DR.
    Infect Immun; 2001 Jul 30; 69(7):4509-15. PubMed ID: 11401993
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A, Hannaman D, Nolan E, Ellefsen B, Nakamura G, Chau L, Tellez O, Little S, Bernard R.
    Vaccine; 2008 Sep 19; 26(40):5216-22. PubMed ID: 18462850
    [Abstract] [Full Text] [Related]

  • 12. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.
    Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
    Sloat BR, Cui Z.
    J Pharm Pharmacol; 2006 Apr 01; 58(4):439-47. PubMed ID: 16597361
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques.
    Livingston BD, Little SF, Luxembourg A, Ellefsen B, Hannaman D.
    Vaccine; 2010 Jan 22; 28(4):1056-61. PubMed ID: 19896452
    [Abstract] [Full Text] [Related]

  • 16. Construction, crystal structure and application of a recombinant protein that lacks the collagen-like region of BclA from Bacillus anthracis spores.
    Liu CQ, Nuttall SD, Tran H, Wilkins M, Streltsov VA, Alderton MR.
    Biotechnol Bioeng; 2008 Mar 01; 99(4):774-82. PubMed ID: 17879302
    [Abstract] [Full Text] [Related]

  • 17. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI, Kudriavtseva OM, Bolothikova MF, Shulepov DV, Novikova LV, Popov IuA, Shchukovskaia TN, Drozdov IG, Kutyrev VV.
    Mol Gen Mikrobiol Virusol; 2007 Mar 01; (3):15-21. PubMed ID: 17886469
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
    Cybulski RJ, Sanz P, McDaniel D, Darnell S, Bull RL, O'Brien AD.
    Vaccine; 2008 Sep 08; 26(38):4927-39. PubMed ID: 18657585
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.